- The announcement marks an exciting new chapter in SC Johnson’s decades long work to create a better world for at-risk populations by scaling distribution of the company’s innovative spatial repellents, Mosquito Shield™ and Guardian™
- The initiative comes as SC Johnson is engaged in multi-year clinical trials to generate safety and efficacy evidence for Mosquito Shield™ and Guardian™, with the goal of obtaining a World Health Organization (WHO) policy recommendation – a critical activation point that would formally recognize the products as the newest official global public health tools and unleash critical partnerships and funding in support of large-scale distribution efforts
- As the need for immediate action is pressing, the leading global manufacturer of household pest control products, with a 70+ year presence in Kenya, is building on its mission to create a healthier world by making a major investment of more than USD 10 million in spatial repellents and malaria eradication
- The initiative leverages the company’s expertise and capabilities to benefit the world’s most vulnerable populations by giving its innovative spatial repellents to public health partners at no cost, providing funding for malaria prevention education, and establishing new health clinics in rural Kenyan communities
Nairobi 26th April 2023 – SC Johnson, the consumer goods company committed to working for a better world, and the government of Kenya, announced a new public-private partnership in the fight against malaria. The initiative builds on the company’s 10-year path to develop and distribute low-cost, long-lasting spatial repellent products that can join widely used interventions like mosquito nets and residual spraying to combat the deadly mosquito-borne disease.
As part of this mission to give back, SC Johnson and Kenya are giving the company’s two innovative spatial repellents, Mosquito Shield™ and Guardian™, to at-risk populations through global public health partners at no cost. The initiative comes as the company is in the process of obtaining World Health Organization policy recommendations for the two tools – a catalysing action point that would accelerate critical partnerships and funding in support of large-scale distribution efforts.
His Excellency William Samoei Ruto, President of the Republic of Kenya
SC Johnson Chairman and CEO Dr. Fisk Johnson and His Excellency Dr. William Samoei Ruto, President of the Republic of Kenya, met and announced the company’s commitment of more than USD 10 million to advance the distribution of the spatial repellents, fund malaria prevention education and build new health clinics in rural Kenyan communities. New manufacturing capacity will come from SC Johnson’s Nairobi facility with a goal of producing enough supply of spatial repellents to reach 17 million people in East Africa annually.
His Excellency William Samoei Ruto, President of the Republic of Kenya, said, “The past few years have demonstrated the importance of Public Private Partnerships in building resilient healthcare systems. My Government and I are committed to ensuring that we attain a healthier and safer country and region that is free from malaria. To achieve this, we are cognisant of the fact that there will be need for new investments, strategic partnerships across different sectors, the need for innovative technologies and advancements that will scale up disease prevention, surveillance, early detection and warning systems.”
“Over and above setting up the right mechanisms for our health care system, this commitment to invest in local manufacturing is a testament to our Kenya Kwanza government promise of boosting industrialization and creating new job opportunities,” he added.
Beyond the benefit to public health initiatives in Kenya, the manufacturing of Mosquito Shield™ and Guardian™ spatial repellents will create at least 150 new jobs in Nairobi, continuing the U.S.-based company’s long-standing presence in Kenya. Local manufacturing will begin this year, with a goal of reaching at-scale manufacturing of Mosquito Shield™ and Guardian™ in 2024.
SC Johnson Chairman and CEO Dr. Fisk Johnson
SC Johnson’s investment also includes USD 1 million to partner with End Malaria Council Kenya to develop malaria prevention education programming, distribute Mosquito Shield™ and Guardian™ spatial repellents through community health workers and clinics, and build new community health clinics to provide vital health services in some of the country’s rural, most hard-to-reach areas.
For over six decades, SC Johnson, the maker of household consumer brands such as Raid®, OFF!® and Baygon®, has devoted its entomological expertise to develop products that provide protection against malaria and other insect-borne diseases. This work is part of a broader set of initiatives to help people who live in some of the most impoverished areas of the world by leveraging the company’s technical knowledge, private capital and core competencies to scale up low-cost and effective solutions for curbing the spread of mosquito-borne diseases.
“This new partnership between SC Johnson and the Government of Kenya is an important next phase in our continuing efforts to help eradicate malaria,” said Fisk Johnson, the Chairman and CEO of SC Johnson. “Through public-private partnerships like this one, SC Johnson is able to contribute to life-saving initiatives by leveraging our resources, expertise and decades-long work to develop and distribute low-cost, effective spatial repellents. As we await a WHO policy recommendation, we want to share those capabilities with the Kenyan people and the continent of Africa in earnest, so more people and families can be saved from the scourge that is malaria.”
Joining His Excellency President Ruto and Dr. Johnson at the State House announcement were Cabinet Secretary for Health, Susan Nakhumicha Wafula, Cabinet Secretary for Trade, Hon. Moses Kuria, and Cabinet Secretary, National Treasury & Economic Planning, Prof. Njuguna Ndung’u. Additionally, the Principal Secretary for Health, Dr. Josephine Mburu, Governor of Nakuru County, Hon. Susan Kihika, and the End Malaria Council Kenya officials were in attendance.
The SC Johnson-Kenya partnership comes as additional momentum is needed in the fight against malaria. Due to widespread insecticide resistance, increasing populations in the East African region and plateauing levels of funding, malaria efforts have stalled in various countries. This has disrupted health programs, including essential services and supply chains, putting further strain on the fight against malaria.
Statistics from the Kenyan Ministry of Health show the country has been able to reduce the burden of malaria by at least 50 percent over the last decade, from a prevalence rate of 11 percent in 2010 to six percent in 2020. However, even with these promising results, Kenya also has seen progress slow.
The new community health clinics SC Johnson has committed to build in Kenya will help address malaria as well as other health issues like HIV/AIDS, family planning, nutrition and access to clean water. Since 2018, the company has established 70 clinics globally across Rwanda, South Sudan, and Indonesia, serving more than one million people annually.